Oncology

The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.

Latest News

FDA headquarters -- Image credit: Tada Images | stock.adobe.com
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus

January 23rd 2025

Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.

Microscopic view of red blood cells (erythrocytes) for a scientific or medical theme
Patients With Myelofibrosis Face Long-Term Treatment and Hospitalization Despite Improvements in Therapy

January 23rd 2025

Blast cell in Acute myeloid leukemia from human blood cells (White blood cells cancer , Bone marrow aspirate)
FDA Approves Treosulfan Regimen For Preparative Use in Stem Cell Transplantation Patients With AML, MDS

January 22nd 2025

cropped view of dermatologist in latex gloves holding dermatoscope while examining patient with skin disease - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
FDA Gives Priority Review to Vusolimogene Oderparepvec for Melanoma

January 22nd 2025

Oncology pharmacist, Breast Cancer, Oncology, Treatment | Image Credit: Dragana Gordic | stock.adobe.com
Advancing Precision Oncology: The Role of Targeted Therapies in HR+, HER2– Breast Cancer

January 22nd 2025

More News

Natural Food Additive Can Prevent Skin Cancer

Natural Food Additive Can Prevent Skin Cancer

Amy Jacob
February 2nd 2016

Annatto is commonly found in the seeds of the achiote fruit.

Read More

Researchers Predict Which Colon Cancer Patients Will Benefit from Chemotherapy

Researchers Predict Which Colon Cancer Patients Will Benefit from Chemotherapy

Lauren Santye, Assistant Editor
February 1st 2016

Newly identified biomarker may help determine whether patients will need chemotherapy post-surgery.

Read More

Lymphoma Treatment Market Poised for Massive Growth

Lymphoma Treatment Market Poised for Massive Growth

Lauren Santye, Assistant Editor
January 31st 2016

Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.

Read More

Approvals and Breakthroughs Highlight Week in Cancer News

Approvals and Breakthroughs Highlight Week in Cancer News

Specialty Pharmacy Times Staff
January 31st 2016

Top news of the week in cancer drug development and research.

Read More

Prostate Cancer Drug Granted Breakthrough Therapy Designation

Prostate Cancer Drug Granted Breakthrough Therapy Designation

Lauren Santye, Assistant Editor
January 30th 2016

Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.

Read More

Prostate Cancer Drug Granted Breakthrough Therapy Designation

Prostate Cancer Drug Granted Breakthrough Therapy Designation

Lauren Santye, Assistant Editor
January 29th 2016

Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.

Read More

Lymphoma Treatment Market Poised for Massive Growth

Lymphoma Treatment Market Poised for Massive Growth

Lauren Santye, Assistant Editor
January 29th 2016

Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.

Read More

NFL Legend Battles Back from Prostate Cancer

NFL Legend Battles Back from Prostate Cancer

Lauren Santye, Assistant Editor
January 28th 2016

NFL Hall of Famer and Super Bowl champion Mike Haynes seeks to spread awareness about prostate cancer following his fight with the disease.

Read More

New Process Helps Find Cancerous Cells During Surgery

New Process Helps Find Cancerous Cells During Surgery

Lauren Santye, Assistant Editor
January 28th 2016

Handheld miniature microscope allows surgeons to see cancer at a cellular level.

Read More

Starting Indoor Tanning Early Linked to Melanoma Diagnoses in Younger Women

Starting Indoor Tanning Early Linked to Melanoma Diagnoses in Younger Women

Amy Jacob
January 28th 2016

Younger melanoma patients undergo indoor tanning more frequently than older women with melanoma.

Read More

Second-Line Metastatic Pancreatic Cancer Treatment Shows Promise

Second-Line Metastatic Pancreatic Cancer Treatment Shows Promise

Lauren Santye, Assistant Editor
January 28th 2016

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Read More

Second-Line Metastatic Pancreatic Cancer Treatment Shows Promise

Second-Line Metastatic Pancreatic Cancer Treatment Shows Promise

Lauren Santye, Assistant Editor
January 27th 2016

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Read More

Genetic Markers May Predict Melanoma Survival

Genetic Markers May Predict Melanoma Survival

Lauren Santye, Assistant Editor
January 27th 2016

Inherited genetic markers in immune response pathways associated with melanoma survival.

Read More

Drug Reduces Cancer Risk in Organ Transplantation

Drug Reduces Cancer Risk in Organ Transplantation

Dava Stewart
January 27th 2016

Sirolimus shows promise in decreasing skin cancer risk among organ transplant patients.

Read More

FDA Approves Expanded Indication for Metastatic Melanoma Combination

FDA Approves Expanded Indication for Metastatic Melanoma Combination

Lauren Santye, Assistant Editor
January 27th 2016

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.

Read More

FDA Approves Expanded Indication for Metastatic Melanoma Combination

FDA Approves Expanded Indication for Metastatic Melanoma Combination

Lauren Santye, Assistant Editor
January 26th 2016

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.

Read More

Near-Infrared Light Drug Delivery Method May Enhance Cancer Treatment

Near-Infrared Light Drug Delivery Method May Enhance Cancer Treatment

Lauren Santye, Assistant Editor
January 26th 2016

New method may offer safer alternative to target tumors and minimize awful side effects for cancer patients.

Read More

Prehistoric Molecular Code Offers New Insight on Cancer Cell Migration

Prehistoric Molecular Code Offers New Insight on Cancer Cell Migration

Lauren Santye, Assistant Editor
January 26th 2016

Researchers find mechanism that enables cells to migrate in a specific tissue.

Read More

Mathematical Formula May Help Predict Cancer Progression

Mathematical Formula May Help Predict Cancer Progression

Lauren Santye, Assistant Editor
January 25th 2016

Researchers find cancer evolves in specific patterns that are predictable through the laws of nature.

Read More

Harnessing Tumor Suppressor Gene May Enhance Cancer Treatment

Harnessing Tumor Suppressor Gene May Enhance Cancer Treatment

Lauren Santye, Assistant Editor
January 25th 2016

Genetic modifications enhance local DNA repair and protection in cancer treatment.

Read More

New Treatment Model Could Improve Ovarian Cancer Survival

New Treatment Model Could Improve Ovarian Cancer Survival

Lauren Santye, Assistant Editor
January 24th 2016

Aggressive surgery to remove all cancer cells followed by targeted chemotherapy shows potential to significantly improve ovarian cancer survival.

Read More

FDA Decisions Highlight Top Cancer News

FDA Decisions Highlight Top Cancer News

Specialty Pharmacy Times Staff
January 24th 2016

Top news of the week in cancer drug development and research.

Read More

PARP Inhibitor Combination Therapy Could Enhance Cancer Treatment

PARP Inhibitor Combination Therapy Could Enhance Cancer Treatment

Lauren Santye, Assistant Editor
January 23rd 2016

Tumors that over-express a specific oncogene may benefit from combination therapy regardless of cancer type.

Read More

Complex Molecule Modifications May Enhance Cancer Drugs

Complex Molecule Modifications May Enhance Cancer Drugs

Lauren Santye, Assistant Editor
January 22nd 2016

New research may transform oncology drug development.

Read More

Spending Bill May Interfere With Evidence-Based Mammagrapy Recommendations

Spending Bill May Interfere With Evidence-Based Mammagrapy Recommendations

Lauren Santye, Assistant Editor
January 22nd 2016

Researchers warn political interference may discourage shared decision-making in breast cancer treatment.

Read More

New Technique Allows for Less Chemotherapy Without Loss of Efficacy in Lung Cancer

New Technique Allows for Less Chemotherapy Without Loss of Efficacy in Lung Cancer

Lauren Santye, Assistant Editor
January 22nd 2016

Use of exomes shield lung cancer drug from immune system defenses.

Read More

Chemotherapy Can Remain Useful After Targeted Therapy in Cancer Treatment

Chemotherapy Can Remain Useful After Targeted Therapy in Cancer Treatment

Lauren Santye, Assistant Editor
January 21st 2016

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Read More

Component in Cotton Could Halt Prostate Cancer Development

Component in Cotton Could Halt Prostate Cancer Development

Lauren Santye, Assistant Editor
January 21st 2016

Byproduct found in cotton plant rid the body of abnormal cancerous cells.

Read More

Chemo Can Remain Useful After Targeted Therapy in Cancer Treatment

Chemo Can Remain Useful After Targeted Therapy in Cancer Treatment

Lauren Santye, Assistant Editor
January 21st 2016

Researchers examine use of docetaxel in patients with castration-resistant metastatic prostate cancer following androgen-deprivation therapy.

Read More

New Technique Allows for Less Chemotherapy Without Loss of Efficacy in Lung Cancer

New Technique Allows for Less Chemotherapy Without Loss of Efficacy in Lung Cancer

Lauren Santye, Assistant Editor
January 20th 2016

Use of exomes shield lung cancer drug from immune system defenses.

Read More

<1
...
194195196197198199200201202
...
229>